Saket Sanghai, MD
Clinical Cardiac Electrophysiology · Portland, ORNPI 1265864474
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (40.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Medtronic at 58.0% of the total. Reporting peaked in 2019 at $24,899 and has fallen 83.4% since, to $4,124 in 2025.
Across 141 payments — averaging $253.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$21K
- Abbott$7K
- Boston Scientific$3K
- Medical Device Business Services, Inc.$2K
- Biotronik Inc.$2K
- Biosense Webster, Inc.$971
What the payments were for
- Consulting fees$2,0006%
- Grants$14,36740%
- Travel & lodging$13,06036%
- Food & beverage$5,63416%
- Education$7512%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 43 | $20,759 |
| Abbott | 48 | $6,581 |
| Boston Scientific | 18 | $3,245 |
| Medical Device Business Services, Inc. | 15 | $2,183 |
| Biotronik Inc. | 8 | $2,073 |
| Biosense Webster, Inc. | 9 | $971 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$2,424
- Ensite Cardiac Mapping System$2,133
- GENERAL - THERAPIES$2,109
- Carto 3 System$1,824
- RHYTHMIA$777
- Carto 3$730
- HeartMate 3 Left Ventricular Dev$206
- AURORA EV-ICD MRI SURESCAN$175
- Amplia MRI$108
- ENSITE$108
- AFFERA MAPPING SYSTEM$102
How this compares
$35,812 in reported general payments places this provider in the 75th percentile of 37 clinical cardiac electrophysiology providers in Oregon.
See all clinical cardiac electrophysiology providers in Oregon →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 76 | $91,274 |
| XareltoRivaroxaban | 15 | $17,185 |
| Dofetilide | 23 | $3,147 |
| Mexiletine Hcl | 16 | $2,786 |
| Metoprolol Succinate | 55 | $1,215 |
| Flecainide Acetate | 29 | $914 |
| Amiodarone Hcl | 33 | $784 |
| SotalolSotalol Hcl | 24 | $589 |
| ClopidogrelClopidogrel Bisulfate | 15 | $275 |
| Omeprazole | 11 | $71 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Portland
- Nathaniel McConkeyPortland$56K
- Michael Charles TanPortland$38K
- Alexi ZemskyPortland$13K
- Darren JonesPortland$11K
- Ryle PrzybylowiczPortland$10K
- Francis PhanPortland$9K
- Charles HenriksonPortland$9K
- Brian MoyersPortland$7K
- Ashkan BabaiePortland$7K
- Fawaz AlhumaidPortland$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.